In conclusion, the PRS of the selected genetic variants for DU risk was mainly associated with actin modification, LRR domain binding, Shaffer IRF4 targets in myeloma vs. mature B lymphocytes, and Reactome runx3 regulated immune response and cell migration. Here, IRF4 is linked to plasma cell myeloma.